Dupixent Succeeds Where Other Biologic Drugs Failed – In COPD

Efficacy In Phase III Trial Exceeded Expectations

 
• By Jessica Merrill
  
key in lock
Dupixent holds a key to success in Phase III • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Respiratory

More from Therapeutic Category